Clinical practice. The thyroid nodule.

By L. Hegedüs. New England Journal of Medicine, 2004

793 citations recorded by the source corpus.

View Paper: https://www.semanticscholar.org/paper/0e053244a07ca568dbd6dc79cc6eb15728ee725e

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

H. Gharib
G. Brent
A. Stagnaro-Ǵreen
E. Pearce
M. Abalovich
R. Negro
Rosalind S. Brown
Herbert Chen

Citations in the corpus

Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and Postpartum (2011, background): “A progressive nodule growth warrants a fine-needle aspiration (FNA), while persistent cough or dysphonia may suggest a malignant lesion (224).”
2017 Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and the Postpartum (2011, background): “, phosphatase and tensin homolog [PTEN] hamartoma tumor syndrome [Cowden’s disease], familial adenomatous polyposis, Carney complex, or Werner syndrome) (441,442,443).”
BRAF mutation in thyroid cancer. (2005, methodology): “Thyroid fineneedle aspiration biopsy (FNAB) with cytological analysis is a widely used initial diagnostic measure in thyroid nodule evaluation (Hegedus 2004).”
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer (2009, unknown): “The clinical importance of thyroid nodules rests with the need to exclude thyroid cancer, which occurs in 7%–15% of cases depending on age, sex, radiation exposure history, family history, and other factors (5,6).”
American Association of Clinical Endocrinologists and Associazione Medici Endocrinologi medical guidelines for clinical practice for the diagnosis and management of thyroid nodules. (2006, background): “Clinical Evaluation Many disorders, both malignant and benign, can cause thyroid nodules (Table 2) (4,9).”
Worldwide Increasing Incidence of Thyroid Cancer: Update on Epidemiology and Risk Factors (2013, background): “The prevalence of malignancy in SN has been estimated at 5% [63].”
Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Taskforce (2006, unknown): “The clinical importance of thyroid nodules rests with the need to exclude thyroid cancer that occurs in 5%–10% depending on age, gender, radiation exposure history, family history, and other factors (4, 5).”
Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer (2009, unknown): “Indeterminate cytology, reported as ‘‘follicular neoplasm’’ or ‘‘Hürthle cell neoplasm’’ can be found in 15–30% of FNA specimens (4) and carries a 20–30% risk of malignancy (42), while lesions reported as atypia or follicular lesion of undetermined significance are variably reported and have 5–10% r”